Viatris (VTRS) Return on Capital Employed (2020 - 2026)
Viatris (VTRS) recorded quarterly Return on Capital Employed of 0.46% in Q1 2026, up 105.28% quarter-over-quarter from 8.74% in Q4 2025, and up 944.0% on a YoY basis from 0.04% in Q1 2025.
Viatris (VTRS) Return on Capital Employed (2020 - 2026) Analysis & Trends
Viatris' Return on Capital Employed history runs 7 years deep, the most recent figure standing at 0.46% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 944.0% year-over-year to 0.46%; the TTM figure through Mar 2026 stood at 0.46% (up 944.0% YoY), while the FY2025 annual figure was 8.26%, down 828.0% from the prior year.
- Return on Capital Employed was 0.46% for Q1 2026 at Viatris, up from 8.74% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 4.01% in Q3 2022 to a low of 8.98% in Q1 2025.
- Historically, Return on Capital Employed has averaged 0.6% across 5 years, with a median of 1.43% in 2024.
- The sharpest annual moves came in 2025 and 2026: Return on Capital Employed slumped 1041 bps in 2025, then soared 944 bps in 2026.
- A 5-year view of Return on Capital Employed shows it stood at 3.79% in 2022, then slumped by 50 bps to 1.89% in 2023, then tumbled by 99 bps to 0.03% in 2024, then tumbled by 32427 bps to 8.74% in 2025, then soared by 105 bps to 0.46% in 2026.
- The last three Return on Capital Employed figures came in at 0.46% (Q1 2026), 8.74% (Q4 2025), and 8.6% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Viatris | - | - | 1.16 Bn | 0.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.46% |
| Dec 31, 2025 | -8.74% |
| Sep 30, 2025 | -8.60% |
| Jun 30, 2025 | -8.31% |
| Mar 31, 2025 | -8.98% |
| Dec 31, 2024 | 0.03% |
| Sep 30, 2024 | -0.71% |
| Jun 30, 2024 | -0.10% |
| Mar 31, 2024 | 1.43% |
| Dec 31, 2023 | 1.89% |
| Sep 30, 2023 | 2.43% |
| Jun 30, 2023 | 2.66% |
| Mar 31, 2023 | 3.00% |
| Dec 31, 2022 | 3.79% |
| Sep 30, 2022 | 4.01% |
| Jun 30, 2022 | 3.44% |
| Mar 31, 2022 | 2.11% |
| Dec 31, 2021 | -0.07% |
| Sep 30, 2021 | -1.78% |
| Jun 30, 2021 | -2.93% |